The Niche

Stem-cell company Novocell brings in genomics CEO

Novocell, a San Diego company developing stem-cell technology for treating diabetes, has named its new CEO. John West has previously held management posts at Applied Biosystems. He was CEO of DNA sequencing company Solexa, until he sold it to Illumina for $600 million. (See the Novocell’s announcement and the San Diego Tribune article. 

BACK TO ARTICLE

Tell a Friend

Please ensure that your friend is content to receive an email from us with a link to the article. Select the following link to view our Privacy Policy.

BACK TO ARTICLE